| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $74.68M | $58.84M | $44.58M | $39.84M | $10.18M |
| Cost of Revenue | $70.95M | $45.24M | $42.59M | $48.27M | $0.00 |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | $192.95M |
| R&D | $475.27M | $314.42M | $241.23M | $155.70M | $135.27M |
| SG&A | $176.59M | $178.18M | $110.82M | $81.60M | $57.68M |
| Operating Income | -$648.13M | -$479.00M | -$350.06M | -$245.73M | -$182.78M |
| Interest Expense | – | – | $97.00K | $55.00K | $2.95M |
| Tax Expense | -$136.00K | -$1.13M | -$4.06M | $0.00 | $0.00 |
| Net Income | -$644.76M | -$463.66M | -$328.07M | -$239.48M | -$186.48M |
| EPS (basic) | -1.4400 | -1.6900 | -1.5800 | -1.3600 | -1.4900 |
| EPS (diluted) | -1.4400 | -1.6900 | -1.5800 | -1.3600 | -1.4900 |
| Shares (diluted) | $447.45M | $274.21M | $207.85M | $175.54M | $125.35M |